SCHEMBL13002811

SCHEMBL13002811

C=CCc1ccccc1O[PH](=O)Oc1ccc(O[PH](=O)Oc2ccccc2C=CC)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
LMNA P02545 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALOX12 P18054 1/20 0.35
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
ADRA2C P18825 3/20 0.35
HTR1A P08908 2/20 0.35
ADRA2A P08913 2/20 0.35
ADRA2B P18089 2/20 0.35
NISCH Q9Y2I1 1/20 0.35
ADRB2 P07550 3/20 0.34
ADRB1 P08588 3/20 0.34
CYP1A2 P05177 2/20 0.34
ADRB3 P13945 1/20 0.34
SLC6A2 P23975 1/20 0.34
BDKRB2 P30411 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15048637 0.81 ADRA2C (0.47) ALDH1A1LMNAADRA2CHTR1AADRA2A
SCHEMBL16361680 0.73 GABRA1 (0.41) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL15048638 0.70 ALDH1A1 (0.47) ALDH1A1LMNAADRA2CHTR1AADRA2A
SCHEMBL1253668 0.68 ALDH1A1 (0.48) ALDH1A1LMNAADRA2CHTR1AADRA2A
SCHEMBL9898069 0.68 NFE2L2 (0.39) ALDH1A1MAPTLMNASMN1; SMN2TSHR
SCHEMBL6849991 0.68 GABRA1 (0.44) ALDH1A1GAAMAPTLMNASMN1; SMN2
SCHEMBL9352980 0.66 HRH1 (0.47) ALDH1A1LMNAADRA2CHTR1AADRA2A
SCHEMBL2822981 0.66 L3MBTL1 (0.50) MAPTADRA2CADRA2AADRA2BNISCH
SCHEMBL31491509 0.66 L3MBTL1 (0.50) MAPTADRA2CADRA2AADRA2BNISCH
SCHEMBL9492872 0.66 HSD17B10 (0.58) ALDH1A1GAALMNASMN1; SMN2ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851528-B2 Flame-retardant resin processed article FUJI ELECTRIC HOLDINGS CO., LTD. (JP) 2010-12-14 US disclosed
US-7834071-B2 Flame-retardant resin processed article FUJI ELECTRIC HOLDINGS CO., LTD. (JP) 2010-11-16 US disclosed
US-20100113654-A1 FLAME-RESISTANT RESIN COMPOSITION FUJI ELECTRIC FA COMPONENTS & SYSTEMS CO., LTD. (JP) 2010-05-06 US disclosed
US-20090105382-A1 FLAME RETARDANT RESIN TREATED ARTICLE FUJI ELECTRIC HOLDINGS CO., LTD (JP) 2009-04-23 US disclosed
US-20090048377-A1 FLAME-RETARDANT RESIN PROCESSED ARTICLE FUJI ELECTRIC HOLDINGS CO., LTD. (JP) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048377-A1 FLAME-RETARDANT RESIN PROCESSED ARTICLE PIK3CA, PFAS, F8 ALDH1A1 4325/4885GAA 2752/4885MAPT 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.